Testing for anti-cyclic citrullinated peptide antibodies: is it time to set this genie free?
Shmerling
Robert H
RH
Division of Rheumatology, Beth Israel Deaconess Medical Center, 110 Francis St, Ste 4B, Boston MA 02215, USA. rshmerli@bidmc.harvard.edu
D000974:Antibodies, Antinuclear / Q000032:analysis* / Q000276:immunology; D001172:Arthritis, Rheumatoid / Q000175:diagnosis* / Q000276:immunology*; D015415:Biomarkers / Q000032:analysis; D042241:Early Diagnosis; D005260:Female; D006801:Humans; D008297:Male; D010456:Peptides, Cyclic / Q000032:analysis* / Q000276:immunology; D012217:Rheumatoid Factor / Q000032:analysis / Q000276:immunology; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index
D000974:Antibodies, Antinuclear; D015415:Biomarkers; D010456:Peptides, Cyclic; C487763:cyclic citrullinated peptide; D012217:Rheumatoid Factor